Pharmaceutical Technology

MAY 11, 2023

The global pharma industry experienced a 9% drop in social media posts on internet of things in Q1 2023 compared with the previous quarter, with the highest share accounted for U.S. Of the 50 leading companies in the pharma industry, U.S. Buy the report here.

Media 52

Media Pharma Competition Marketing 52

European Pharmaceutical Review

APRIL 28, 2023

The European Commission ’s (EC’s) reform of the EU pharmaceutical legislation published on 26 April 2023, adopted a proposal for a new Directive and a new Regulation. To mitigate this, he strongly recommended “a comprehensive competitiveness check is conducted on the impact of the revised pharmaceutical legislation.”

Pharmaceutical 98

Pharmaceutical Pharma Medicine Competition 98

Impetus Digital

AUGUST 2, 2024

Looking back at 2023 , AI for drug discovery saw both wins and losses. Supply Chain Management Due to geopolitical and climate-related challenges , Pharma supply chain disruptions are becoming increasingly common and complex. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.

Pharma 95

Pharma Manufacturing Medicine Marketing 95

PM360

SEPTEMBER 21, 2023

Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.

Management 105

Management Manufacturing Sales Competition 105

pharmaphorum

JANUARY 9, 2023

This Nine for 2023 three-part series will argue that, this year, the future-facing Janus prediction of unprecedented and transformative change is true. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.

Medicine 86

Medicine Healthcare Healthcare Pharma 86

European Pharmaceutical Review

SEPTEMBER 13, 2023

As small and medium-sized enterprises (SMEs) often face unfair competition when doing business in Europe, through the (SME) Relief Communication, the European Commission (EC) has proposed new measures to provide short-term relief, boost long-term competitiveness, and improve equality in the business environment across the Single Market in Europe.

Pharma 96

Pharma Competition Marketing Training 96

European Pharmaceutical Review

MARCH 7, 2023

The Pistoia Alliance has launched its Pharma Innovation Council. The Council will explore common challenges develop ideas for new pre-competitive projects aligned with the Alliance’s strategic themes, including Emerging Sciences and Technology and Improving the Efficiency and Effectiveness of R&D.

Pharma 92

Pharma Leads Consulting Competition 92

Clarivate

MAY 8, 2024

A glance at the 2023 and early 2024 life science dealmaking environment shows fewer, but higher-value, transactions. As a result, 2023 saw an upsurge in merger and acquisition (M&A) and deal activity. According to BioWorld, M&A values in 2023 jumped 80% over 2022, and deal values reached BioWorld’s highest level ever recorded.

Pharma 59

Pharma Biopharma Prospecting Competition 59

Star OUTiCO

NOVEMBER 30, 2022

January is one of the busiest recruiting times, so starting your hunt this month could mean lower competition and possibly improve your odds of securing your dream job. Reassess ahead of 2023. Some larger pharma clients are really going above and beyond to try and dangle that golden carrot Sarah Whitby, Pharma Outsourcing Lead.

Recruitment 98

Recruitment Pharma Leads Competition 98

Pharma Marketing Network

MARCH 23, 2023

As cookies become obsolete, pharma marketers will need to find new ways to reach and engage with consumers. For example, pharma marketers can use email marketing to reach consumers with relevant health and wellness information, or use SMS marketing to send appointment reminders or refill notifications. References: 1. ” Hubspot.

Marketing 52

Marketing Pharma Consulting Competition 52

pharmaphorum

DECEMBER 15, 2022

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. “The industry now regards the current approach, due to end in 2023, as broken.” VPAS tax on top. . VPAS tax on top. .”

Pharma 72

Pharma Government Manufacturing Medicine 72

pharmaphorum

SEPTEMBER 5, 2022

The UK Competition and Markets Authority (CMA) is seeking to disqualify Peter Butterfield, currently chief executive of Alliance Pharma, from serving as a company director. ” The action will only be heard if the Competition Appeal Tribunal (CAT) upholds the CMA’s findings against Alliance, it added. .”

Pharma 59

Pharma Competition Management Marketing 59

Pharmaceutical Technology

JANUARY 30, 2023

on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. During 2019–21, when sales being close to predicted levels resulted in single-digit payback rates, the scheme was relatively popular with the pharma sector. billion ($4.1

Government 97

Government Pharma Sales Medicine 97

Clarivate

DECEMBER 19, 2022

For 2023 Medicare Advantage open enrollment, the United States’ largest retailer will begin a 10-year partnership with the nation’s largest insurer. The partnership dovetails with Walmart Health’s plans for 15 new Florida clinics across the Jacksonville, Orlando and Tampa markets by the end of 2023. MA national enrollment.

Competition 52

Competition Retail Insurance Marketing 52

Pharmaceutical Technology

MAY 16, 2023

More than half of the top 20 global biopharmaceutical companies saw a fall in market capitalisation over Q1 2023. trillion in Q1 2023, according to GlobalData’s pharma intelligence centre companies database. This resulted in a 3.4% decline in total aggregate market capitalisation from $3.61 trillion in Q4 2022 to $3.49

Marketing 52

Marketing Sales Pharma Leads 52

Clarivate

SEPTEMBER 17, 2024

From the record-breaking heights of the COVID-19 era to the recent slowdown in 2023, signs of resilience and recovery are beginning to emerge. One key factor driving this recovery is the continued investor and big pharma interest in innovative technologies and groundbreaking research. Please join us – you can register here.

Pharma 59

Pharma Competition Healthcare Healthcare 59

PharmaKinnex

SEPTEMBER 28, 2022

How PharmaKinnex Helps You Plan For A Better 2023 September 27, 2022. Everyone knows that over the next few weeks and months, businesses in the pharma marketing industry will meet to discuss next year’s budget. Keep reading to find out more about how our pharma marketing services can help make 2023 your best year yet.

Sales 52

Sales Pharma Marketing Prospecting 52

Eversana Intouch

JANUARY 19, 2023

Success in 2023 will mean addressing each of those five issues meaningfully – understanding them fully and giving them real action, not just lip service. – is changing, and has big implications for the competitive marketplace. Pharma marketers in 2023 need to: Look for blind spots. or technology, too?

Medical 52

Medical Education Competition Marketing 52

European Pharmaceutical Review

NOVEMBER 30, 2023

Cell and gene therapy industry in 2023 According to data from the GMP Manufacturing Survey, in the past year: “There is an increase in the number of manufacturing organisations and the number of licensed facilities has remained stable. The 2023 data found that the split for bioprocessing roles was 57 percent.

Manufacturing 97

Manufacturing Recruitment Medicine Biopharma 97

PM360

APRIL 7, 2023

However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. pharma sales in 2020) and the size of 340B discounts (25-50%), companies may see significantly reduced revenues for important products.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

World of DTC Marketing

MARCH 17, 2021

The rapid rollout of Covid-19 vaccines has made household names of Pfizer and AstraZeneca, and the whole industry is winning praise for co-operation” However, the bump in reputation will be short-lived because companies need to earn the public’s trust every day, and pharma is already damaging their perception with people.

Pharma 186

Pharma Competition Prescription Sales 186

Medico Reach

FEBRUARY 8, 2023

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. Are you intrigued to know what technologies will rule the pharma market and how they can benefit your business in 2023? from 2022 to 2030, the pharma industry will reach USD 9,241.34 billion during 2020-2024.

Pharma 52

Pharma Medicine Marketing Prospecting 52

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.

Pharma 109

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 109

pharmaphorum

JANUARY 16, 2023

The present article focuses on opportunity, the unmet need which lies at the heart of better healthcare provision, and two areas of growth and opportunity: Point of Care Diagnostics, and the new pharmacotherapy classes which will commercialise for the first time in 2023. Innovation will power the market.

FDA 85

FDA Healthcare Healthcare Medicine 85

PM360

SEPTEMBER 30, 2024

This article outlines how developers can utilize sustainability initiatives to boost revenue, reduce costs, and advance innovation, ensuring a strategic, long-term, and more sustainable position in today’s competitive landscape. Continued innovation is crucial in enhancing sustainability within pharma and the broader biotech industry.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

pharmaphorum

JANUARY 5, 2023

As Chancellor of the Exchequer Jeremy Hunt said: “I want British firms to lead the world in turning fantastic science into new products and services – and we need to make sure government is doing everything we can to encourage innovation and competition.”. The post It’s time for more tech and biotech innovation in 2023 appeared first on.

Manufacturing 93

Manufacturing Government Leads Electronics 93

PM360

OCTOBER 13, 2023

For the next 12 to 24 months, the media landscape is set to drastically change and pharma marketers can’t miss this hidden opportunity. billion in 2023 from these fees. Threads on the other hand is the spitting image of brand safety—if pharma developed an industry-centric platform, this would be it. Will streaming evolve?

Media 69

Media Pharma Networking Safety 69

Clarivate

JANUARY 23, 2024

The just-published 2023 Factbook indicates an industry that is becoming more nimble and efficient in its R&D over the long haul. Figure 1: Number of NME launches from 2013 to 2022 Analyses from the 2023 R&D Factbook also indicate that the number of late phase terminations has consistently declined in recent years.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

Clarivate

MAY 31, 2023

A glance at the 2022 top selling drugs for the biggest pharma companies reveals how dependent many large pharmas are on a small basket of products – most acquired through partnerships or acquisitions – that are nearing loss of exclusivity. Pharma is placing bigger bets on a smaller number of therapeutics and technology platforms.

Pharma 52

Pharma Biopharma Medicine Healthcare 52

eMediWrite

AUGUST 30, 2023

Pharma MSMEs might not have the negotiation leverage or other options necessary to properly handle late payments. Challenges posed by payments that are late for pharma MSMEs For pharma MSMEs, late payments present formidable obstacles. The solution to the issue of delayed payments is collaboration.

Pharma 52

Pharma Government Pharmaceutical Electronics 52

Healthcare Success

NOVEMBER 7, 2022

They’re researching key trends that will attract new high-intent audiences, increase engagement, drive revenue, and reinforce patient loyalty in 2023. In this article, you’ll learn: 4 Advertising Planning Strategies for 2023 6 Marketing Strategies That Outpace Market Disruption. 4 Advertising Planning Strategies for 2023.

Marketing 52

Marketing Media Healthcare Healthcare 52

Pharma Marketing Network

DECEMBER 17, 2021

The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. HCP Engagement and Pharma Salesforces.

Pharma 105

Pharma Marketing Engineering Digital Media 105

Star OUTiCO

DECEMBER 1, 2023

This time of year is particularly competitive for recruitment within pharma, medtech, and biotech, so setting goals and staying organised will help you immeasurably. ‘ This time of year is particularly competitive for recruitment within pharma, medtech, and biotech, so setting goals and staying organised will help you immeasurably. ‘

Pharma 52

Pharma Recruitment Networking Consulting 52

European Pharmaceutical Review

MAY 13, 2024

Notably, 47 percent of respondents from the pharma and healthcare sectors considered that financial performance was “the main task of procurement”. Sustainability of the future pharma supply chain “Companies are now receiving uniform rules for the entire EU, which is particularly advantageous for the healthcare industry.

Healthcare 100

Healthcare Healthcare Pharmaceutical Pharma 100

pharmaphorum

SEPTEMBER 15, 2022

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”

Competition 99

Competition Consulting Marketing Pharma 99

European Pharmaceutical Review

NOVEMBER 8, 2022

Under two other pending bills – House of Representatives Bill 2883, titled Stop Stalling Access to Affordable Medications, and Senate Bill 1425, titled Stop STALLING 4 Act – it would be unfair competition to submit an “objectively baseless petition” to the FDA in an attempt to interfere with a competitor’s application to market a drug.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

pharmaphorum

JULY 21, 2022

The appointment might raise some eyebrows given Roche’s need to drive pharma sales as it copes with the loss of patent protection on an earlier generation of antibody-based therapies – now being hit by biosimilar competition – but Schwan is confident Schinecker is the right man to lead the company forward. billion ($33.2

Sales 113

Sales Pharma Competition Management 113